VOYA Investment Management
SAGE

VOYA Investment Management’s Sage Therapeutics SAGE Stock Holding History

VOYA Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,328
Closed -$140K – 2617
2025
Q2 		$140K Sell
15,328
-33,445
-69% -$246K ﹤0.01% 2406
2025
Q1 		$388K Buy
48,773
+6,818
+16% +$49.9K ﹤0.01% 1986
2024
Q4 		$228K Buy
41,955
+7,319
+21% +$44.7K ﹤0.01% 2336
2024
Q3 		$250K Buy
34,636
+16,624
+92% +$152K ﹤0.01% 2361
2024
Q2 		$196K Buy
18,012
+591
+3% +$7.57K ﹤0.01% 2484
2024
Q1 		$326K Sell
17,421
-3,629
-17% -$83.7K ﹤0.01% 2213
2023
Q4 		$456K Sell
21,050
-76,819
-78% -$1.52M ﹤0.01% 2126
2023
Q3 		$2.01M Buy
97,869
+19,212
+24% +$555K ﹤0.01% 1329
2023
Q2 		$3.7M Buy
78,657
+58,818
+296% +$2.93M ﹤0.01% 1121
2023
Q1 		$832K Sell
19,839
-249
-1% -$10.7K ﹤0.01% 1761
2022
Q4 		$766K Hold
20,088
– – ﹤0.01% 1779
2022
Q3 		$787K Sell
20,088
-59,736
-75% -$2.31M ﹤0.01% 1757
2022
Q2 		$2.58M Buy
79,824
+14,283
+22% +$479K 0.01% 1000
2022
Q1 		$2.17M Sell
65,541
-873
-1% -$32.8K ﹤0.01% 1083
2021
Q4 		$2.83M Buy
66,414
+58,124
+701% +$2.43M 0.01% 1013
2021
Q3 		$367K Buy
8,290
+44
+0.5% +$2.02K ﹤0.01% 2227
2021
Q2 		$468K Buy
8,246
+200
+2% +$14.1K ﹤0.01% 2131
2021
Q1 		$602K Sell
8,046
-295
-4% -$24.2K ﹤0.01% 1922
2020
Q4 		$722K Sell
8,341
-523
-6% -$38.5K ﹤0.01% 1688
2020
Q3 		$542K Sell
8,864
-365
-4% -$18.5K ﹤0.01% 1630
2020
Q2 		$384K Sell
9,229
-9,037
-49% -$328K ﹤0.01% 1823
2020
Q1 		$525K Sell
18,266
-681
-4% -$39.4K ﹤0.01% 1598
2019
Q4 		$1.37M Sell
18,947
-6,186
-25% -$761K ﹤0.01% 1282
2019
Q3 		$3.53M Buy
25,133
+251
+1% +$42K 0.01% 883
2019
Q2 		$4.56M Sell
24,882
-1,153
-4% -$197K 0.01% 828
2019
Q1 		$4.14M Sell
26,035
-1,678
-6% -$243K 0.01% 842
2018
Q4 		$2.65M Sell
27,713
-472
-2% -$54K 0.01% 932
2018
Q3 		$3.98M Sell
28,185
-1,510
-5% -$233K 0.01% 896
2018
Q2 		$4.65M Sell
29,695
-279,268
-90% -$43.8M 0.01% 834
2018
Q1 		$49.8M Buy
308,963
+291,884
+1,709% +$49.6M 0.11% 205
2017
Q4 		$2.81M Buy
17,079
+1,054
+7% +$102K 0.01% 961
2017
Q3 		$998K Hold
16,025
– – ﹤0.01% 1433
2017
Q2 		$1.28M Buy
16,025
+4,371
+38% +$316K ﹤0.01% 1247
2017
Q1 		$828K Sell
11,654
-148,976
-93% -$8.73M ﹤0.01% 1438
2016
Q4 		$8.2M Sell
160,630
-107,308
-40% -$5.06M 0.02% 647
2016
Q3 		$12.3K Sell
267,938
-91,875
-26% -$3.74M 0.02% 506
2016
Q2 		$10.8M Buy
+359,813
New +$12M 0.03% 541
2016
Q1 		– Sell
-5,616
Closed -$327K – 2527
2015
Q4 		$327K Hold
5,616
– – ﹤0.01% 2004
2015
Q3 		$238K Sell
5,616
-1,020
-15% -$62.9K ﹤0.01% 2175
2015
Q2 		$484K Buy
+6,636
New +$427K ﹤0.01% 1960

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

VOYA Investment Management's SAGE Position: Q3 2025 in Review

VOYA Investment Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 15,328 shares — an estimated $140K sold.

VOYA Investment Management first reported a position in SAGE in Q2 2015 and held it in 40 quarters. The position peaked at $49.8M in Q1 2018. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • VOYA Investment Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 15,328 Sage Therapeutics shares in Q3 2025, an estimated $140K.
  • VOYA Investment Management first reported a position in Sage Therapeutics in Q2 2015 and held it in 40 quarters.
  • VOYA Investment Management's Sage Therapeutics position peaked at $49.8M in Q1 2018.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.